Metal Non-Covered Biliary Stent Market Report Overview
-
Request a Free Sample to learn more about this report
The global metal non-covered biliary stent market size was USD 354.5 million in 2022 and is projected to touch USD 521.7 million by 2031, at CAGR of 4.4% during the forecast period.
The COVID-19 pandemic has been unprecedented and staggering, with metal non-covered biliary stent experiencing higher-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden rise in CAGR is attributable to the market’s growth and demand returning to pre-pandemic levels.
A metal non-covered biliary stent is a medical device used in the treatment of biliary strictures or obstructions. The biliary system consists of ducts that carry bile, a digestive fluid, from the liver to the small intestine. When these ducts become blocked or narrowed, it can lead to various complications, such as jaundice or infection. Biliary stents are designed to restore the normal flow of bile by creating a pathway through the obstruction. Unlike covered biliary stents, which are coated with a synthetic material, metal non-covered stents are made entirely of metal, typically stainless steel or nitinol. The use of metal provides several advantages. Firstly, metal stents have a higher radial force, meaning they are more resistant to compression and collapse, which helps maintain the patency of the stent. Additionally, the absence of a covering allows for better tissue ingrowth into the stent, promoting long-term stability and reducing the risk of migration.
The metal non-covered biliary stent market refers to the segment of the medical devices industry that focuses on the production and distribution of metal stents used for treating biliary disorders. These stents are designed to provide support and maintain the patency of the bile ducts, ensuring the proper flow of bile from the liver to the small intestine. Metal non-covered biliary stents are primarily used in the treatment of various biliary diseases, including biliary strictures, malignant and benign biliary obstructions, and postoperative biliary leaks.
COVID-19 Impact: Pandemic Caused Postponement or Cancellation of Elective Procedures Hampering the Market Growth
The outbreak of the COVID-19 pandemic has had a significant impact on the metal non-covered biliary stent market. Firstly, the pandemic has led to disruptions in the healthcare systems globally, with resources and medical personnel being redirected towards managing COVID-19 patients. This has resulted in the postponement or cancellation of elective procedures, including those involving the placement of biliary stents. As a result, the market witnessed a decline in procedural volumes during the initial phase of the pandemic. Additionally, the economic impact of the pandemic has affected healthcare budgets, leading to reduced healthcare expenditures in some regions. This has further impacted the market growth as hospitals and healthcare facilities focused on essential medical supplies and equipment, leading to a decreased demand for non-urgent procedures such as biliary stenting.
Latest Trends
"Increasing Preference for Minimally Invasive Procedures to Boost the Market Development"
Minimally invasive techniques, such as endoscopic retrograde cholangiopancreatography (ERCP), have gained popularity due to their advantages, including shorter hospital stays, reduced postoperative pain, and faster recovery times. Metal non-covered biliary stents are commonly placed during ERCP procedures for the treatment of biliary obstructions. The trend towards minimally invasive procedures is driving the demand for metal non-covered biliary stents as they are well-suited for such techniques.
Metal Non-Covered Biliary Stent Market Segmentation
-
Request a Free Sample to learn more about this report
- By Type Analysis
According to type, the market can be segmented into absorbable, non-absorbable. Absorbable being the leading segment of the market by type analysis.
- By Application Analysis
Based on application, the market can be divided into Hospital, Medical Center. Hospital being the leading segment of the market by application analysis.
Driving Factors
"Growing Prevalence of Biliary Disorders to Drive the Market Growth"
The increasing prevalence of biliary disorders, including biliary strictures, bile duct stones, and bile duct cancers, is a major driver for the metal non-covered biliary stent market. Factors such as an aging population, lifestyle changes, and the rising incidence of risk factors like obesity and diabetes contribute to the higher prevalence of biliary disorders. As the number of patients diagnosed with these conditions rises, the demand for metal non-covered biliary stents increases, as they are a crucial treatment modality for managing such disorders.
"Technological Advancements in Stent Design to Drive the Market Development"
Advancements in stent design have significantly improved the efficacy and safety of metal non-covered biliary stents. The introduction of self-expanding stents and the development of new materials with improved biocompatibility and durability have enhanced the performance of these stents. Moreover, the integration of advanced imaging technologies, such as fluoroscopy and endoscopic ultrasound, allows for precise stent placement and better patient outcomes. These technological advancements drive the adoption of metal non-covered biliary stents and contribute to market growth.
Restraining Factors
"Risk of Stent-Related Complications to Impede the Market Growth"
Although metal non-covered biliary stents offer effective treatment for biliary disorders, they are associated with potential complications, such as stent migration, stent occlusion, and tissue ingrowth. The occurrence of these complications can lead to additional interventions, increased healthcare costs, and patient discomfort. Manufacturers and healthcare professionals must focus on developing and implementing strategies to minimize these complications and improve patient outcomes.
Metal Non-Covered Biliary Stent Market Regional Insights
-
Request a Free Sample to learn more about this report
"High Prevalence of Biliary Disorders, Including Biliary Strictures, Bile Duct Stones, And Bile Duct Cancers in North America to Bolster the Market Development"
The North American market for metal non-covered biliary stents holds significant potential due to several factors. Firstly, the region has a high prevalence of biliary disorders, including biliary strictures, bile duct stones, and bile duct cancers. This can be attributed to factors such as lifestyle changes, obesity rates, and an aging population. The increasing incidence of these disorders drives the demand for effective treatment options, including metal non-covered biliary stents. Additionally, North America boasts advanced healthcare infrastructure, including well-equipped hospitals and specialized healthcare centers. The availability of advanced imaging technologies and experienced healthcare professionals contributes to the adoption of metal non-covered biliary stents. The region's robust healthcare system enables efficient diagnosis, treatment, and management of biliary disorders, further fueling the market growth.
The Asia Pacific region is poised to experience substantial growth in the metal non-covered biliary stent market. This can be attributed to various factors, starting with the increasing prevalence of biliary disorders in the region. Rapid urbanization, changing lifestyles, and an aging population contribute to the rising incidence of biliary conditions such as biliary strictures and bile duct stones. As the number of patients diagnosed with these disorders increases, the demand for effective treatment options, including metal non-covered biliary stents, is expected to rise significantly. Furthermore, the Asia Pacific region has been witnessing rapid healthcare infrastructure development. Countries such as China, India, and Japan have been making significant investments in healthcare facilities, including hospitals, clinics, and specialized healthcare centers. This improved infrastructure supports the diagnosis, treatment, and management of biliary disorders, driving the demand for metal non-covered biliary stents.
Key Industry Players
"Key Players Focus on Partnerships to Gain a Competitive Advantage "
Prominent market players are making collaborative efforts by partnering with other companies to stay ahead of the competition. Many companies are also investing in new product launches to expand their product portfolio. Mergers and acquisitions are also among the key strategies used by players to expand their product portfolios.
List of Market Players Profiled
- Boston Scientific (U.S.)
- Taewoong Medical (South Korea)
- Merit Medical (U.S.)
- Cook Medical (U.S.)
- PNN Medical (Denmark)
- Teleflex (U.S.)
- C.R. Bard (U.S.)
Report Coverage
This research profiles a report with extensive studies that take into description the firms that exist in the market affecting the forecasting period. With detailed studies done, it also offers a comprehensive analysis by inspecting the factors like segmentation, opportunities, industrial developments, trends, growth, size, share, and restraints. This analysis is subject to alteration if the key players and probable analysis of market dynamics change.
REPORT COVERAGE | DETAILS |
---|---|
Market Size Value In |
US$ 354.5 Million in 2022 |
Market Size Value By |
US$ 521.7 Million by 2031 |
Growth Rate |
CAGR of 4.4% from 2022 to 2031 |
Forecast Period |
2024-2031 |
Base Year |
2023 |
Historical Data Available |
Yes |
Regional Scope |
Global |
Segments Covered |
Type and Application |
Frequently Asked Questions
-
What value is the metal non-covered biliary stent market expected to touch by 2031?
The global metal non-covered biliary stent size is expected to reach USD 521.7 million by 2031.
-
What CAGR is the metal non-covered biliary stent market expected to exhibit by 2031?
The metal non-covered biliary stent is expected to exhibit a CAGR of 4.4% by 2031.
-
Which are the driving factors of the Metal Non-Covered Biliary Stent market?
Growing prevalence of biliary disorders and technological advancements in stent design are the driving factors of the Metal Non-Covered Biliary Stent market.
-
Which are the key players or most dominating companies functioning in the Metal Non-Covered Biliary Stent market?
The dominating companies in the Metal Non-Covered Biliary Stent market are Boston Scientific, Taewoong Medical, Merit Medical, Cook Medical and PNN Medical.